Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Increased inflammatory response in patients with dilated cardiomyopathy is associated with dyslipidemia: Effects of statin therapy.

Iakovis P, Anyfantakis ZA, Limas C, Kroupis C, Degiannis D, Cokkinos DV.

Angiology. 2011 Jan;62(1):55-61. doi: 10.1177/0003319710384396.

PMID:
21134995
2.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

3.

Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.

Manfredini V, Biancini GB, Vanzin CS, Dal Vesco AM, Cipriani F, Biasi L, Treméa R, Deon M, Peralba Mdo C, Wajner M, Vargas CR.

Cell Biochem Funct. 2010 Jul;28(5):360-6. doi: 10.1002/cbf.1654.

PMID:
20589733
4.

Effects of preoperative statin therapy on cytokines after cardiac surgery.

Liakopoulos OJ, Dörge H, Schmitto JD, Nagorsnik U, Grabedünkel J, Schoendube FA.

Thorac Cardiovasc Surg. 2006 Jun;54(4):250-4.

PMID:
16755446
5.

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK.

Clin Cardiol. 2004 Apr;27(4):199-203.

6.

In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.

Panichi V, Paoletti S, Mantuano E, Manca-Rizza G, Filippi C, Santi S, Taccola D, Donadio C, Tramonti G, Innocenti M, Casto G, Consani C, Sbragia G, Franzoni F, Galetta F, Panicucci E, Barsotti G.

Nephrol Dial Transplant. 2006 Feb;21(2):337-44. Epub 2005 Oct 25.

PMID:
16249194
7.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators.

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
8.

The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.

Bielecka-Dabrowa A, Goch JH, Mikhailidis DP, Rysz J, Maciejewski M, Banach M.

Med Sci Monit. 2009 Dec;15(12):MS12-23.

PMID:
19946241
10.

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates.

Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Herman ZS.

J Cardiovasc Pharmacol. 2005 Sep;46(3):377-86.

PMID:
16116345
12.

Vascular effects of diet and statin in hypercholesterolemic patients.

Koh KK, Son JW, Ahn JY, Jin DK, Kim HS, Choi YM, Ahn TH, Kim DS, Shin EK.

Int J Cardiol. 2004 Jun;95(2-3):185-91.

PMID:
15193818
13.

Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.

Kaya C, Pabuccu R, Cengiz SD, Dünder I.

Exp Clin Endocrinol Diabetes. 2010 Mar;118(3):161-6. doi: 10.1055/s-0029-1220770. Epub 2010 Feb 9.

PMID:
20146169
14.

Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.

Hernandez TL, Capell WH, Wolfe P, Gerard LA, Eckel RH.

Am J Cardiol. 2006 Dec 15;98(12):1656-9. Epub 2006 Oct 25.

PMID:
17145229
15.

[The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].

Broncel M, Koter-Michalak M, Chojnowska-Jezierska J.

Przegl Lek. 2006;63(9):738-42. Polish.

PMID:
17479860
16.

Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

Goldberger JJ, Subacius H, Schaechter A, Howard A, Berger R, Shalaby A, Levine J, Kadish AH; DEFINITE Investigators.

J Am Coll Cardiol. 2006 Sep 19;48(6):1228-33. Epub 2006 Aug 28.

18.

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN; COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.

Clin Ther. 2007 Jul;29(7):1354-67.

PMID:
17825687
19.

Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.

Bulcão C, Ribeiro-Filho FF, Sañudo A, Roberta Ferreira SG.

Am J Cardiovasc Drugs. 2007;7(3):219-24.

PMID:
17610348
20.

The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.

Gürgün C, Ildizli M, Yavuzgil O, Sin A, Apaydin A, Cinar C, Kültürsay H.

Int J Cardiol. 2008 Jan 11;123(2):102-7. Epub 2007 Feb 22.

PMID:
17320212

Supplemental Content

Support Center